[go: up one dir, main page]

CN103239426A - Preparation of a kind of far-infrared gel composition and gel ointment - Google Patents

Preparation of a kind of far-infrared gel composition and gel ointment Download PDF

Info

Publication number
CN103239426A
CN103239426A CN2012100226009A CN201210022600A CN103239426A CN 103239426 A CN103239426 A CN 103239426A CN 2012100226009 A CN2012100226009 A CN 2012100226009A CN 201210022600 A CN201210022600 A CN 201210022600A CN 103239426 A CN103239426 A CN 103239426A
Authority
CN
China
Prior art keywords
far
gel composition
infrared
gel
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2012100226009A
Other languages
Chinese (zh)
Other versions
CN103239426B (en
Inventor
张昕
张鼎樑
朱正林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fang Shanghai Pharmaceutical Technology Co ltd
Original Assignee
Shanghai Ciji Pharmaceutical Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Ciji Pharmaceutical Co ltd filed Critical Shanghai Ciji Pharmaceutical Co ltd
Priority to CN201210022600.9A priority Critical patent/CN103239426B/en
Publication of CN103239426A publication Critical patent/CN103239426A/en
Application granted granted Critical
Publication of CN103239426B publication Critical patent/CN103239426B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

本发明涉及一种医用膏贴的技术领域,具体公开了一种药用凝胶组合物(膏体)及凝胶膏剂的制备。以所述凝胶组合物的总重量计,它含有以下组分:远红外材料3~7wt%、植物提取物20~35wt%、丙烯酸树脂1~4wt%、交联剂0.1~0.4wt%、保湿剂20~35wt%、透皮促进剂1.5~3.0wt%、填充剂1~3wt%、粘合剂5~7wt%、余量为水;其中所述远红外材料选自托玛琳或麦饭石;所述丙烯酸树脂选自丙烯酸与丙烯酸钠的共聚物或聚丙烯酸钠。本发明的凝胶组合物具有磁疗的功能;同时,由于其独特配方而又具有良好的交联性能,在贴敷时不会出现膏体渗漏现象,使用方便。The invention relates to the technical field of medical plasters, and specifically discloses the preparation of a medicinal gel composition (paste) and gel plaster. Based on the total weight of the gel composition, it contains the following components: 3-7 wt% of far-infrared material, 20-35 wt% of plant extract, 1-4 wt% of acrylic resin, 0.1-0.4 wt% of crosslinking agent, 20-35wt% moisturizer, 1.5-3.0wt% skin penetration enhancer, 1-3wt% filler, 5-7wt% binder, and water as the balance; wherein the far-infrared material is selected from tourmaline or wheat Rice stone; the acrylic resin is selected from the copolymer of acrylic acid and sodium acrylate or sodium polyacrylate. The gel composition of the present invention has the function of magnetic therapy; at the same time, because of its unique formula and good cross-linking performance, there will be no ointment leakage during sticking, and it is convenient to use.

Description

一种远红外凝胶组合物及凝胶膏剂的制备Preparation of a kind of far-infrared gel composition and gel ointment

技术领域 technical field

本发明涉及一种医用膏贴的技术领域,具体公开了一种药用凝胶组合物(膏体)及凝胶膏剂的制备。The invention relates to the technical field of medical plasters, and specifically discloses the preparation of a medicinal gel composition (paste) and gel plaster.

背景技术 Background technique

凝胶膏剂(曾用名巴布剂Gataplasma)20世纪70年代源自日本,80年代初引入我国,90年代我国开始规模生产中药凝胶膏剂。2010版《中国药典》一部对凝胶膏剂的定义是:系指提取物、饮片或和化学药物与适宜的亲水性基质混匀后,涂布于背衬材料上制成的贴膏剂。Gel ointment (formerly known as cataplasm Gataplasma) originated from Japan in the 1970s and was introduced into my country in the early 1980s. In the 1990s, my country began to produce traditional Chinese medicine gel ointment on a large scale. The definition of gel ointment in the 2010 edition of "Chinese Pharmacopoeia" is: it refers to the plaster made by mixing the extract, decoction pieces or chemical drugs with a suitable hydrophilic matrix, and then coating on the backing material.

凝胶膏剂是以水溶性高分子聚合物为基质骨架材料的外用贴剂,具有载药量大、可反复贴用、舒适、无刺激性和过敏性、透气保湿、渗透性好等优点。由于中药都以复方入药,有效成分提取纯化比较困难,多半是提取精制成一定浓度的浸膏再制成相应的制剂要达到应有疗效一般用药量较大,而凝胶膏剂的优势是载药量大,又可反复揭贴,再贴上时依然可以保持很好的黏性,故凝胶膏剂在药用制剂领域的应用前景十分广泛。Gel ointment is an external patch with water-soluble polymer as the matrix and skeleton material. It has the advantages of large drug loading, reusable application, comfort, non-irritating and allergic, breathable and moisturizing, and good permeability. Since traditional Chinese medicines are all used as compound prescriptions, it is difficult to extract and purify the active ingredients. Most of them are extracted and refined into extracts of a certain concentration and then made into corresponding preparations to achieve the desired curative effect. The amount of medicine is large, and it can be peeled off repeatedly, and it can still maintain good viscosity when pasted again. Therefore, the application prospect of gel ointment in the field of pharmaceutical preparations is very wide.

远红外辐射材料(以下简称:远红外材料)如托玛琳、麦饭石等及其相关产品已在国内研制并上市,如中脉科技的中科暖内衣、被、单、枕等。据研究证实:远红外透入机体,通过共振吸收,起到微按摩作用,具有非热效应,该效应能扩张局部毛细血管,促进细胞膨胀成多孔状态,促进药物吸收,并加快微循环,促进细胞新陈代谢,起到活血化瘀的治疗作用,真正体现中医理论“通则不痛”的治疗法则。而托玛琳、麦饭石等作为治疗急、慢性扭伤、软组织损伤类型的凝胶膏剂的功效成分之一亦未见报道。Far-infrared radiation materials (hereinafter referred to as: far-infrared materials) such as tourmaline, medical stone, etc. and related products have been developed and marketed in China, such as Zhongke warm underwear, quilts, sheets, pillows, etc. of Zhongmai Technology. According to research, it has been confirmed that far infrared penetrates into the body, and through resonance absorption, it acts as a micro-massage. It has a non-thermal effect. This effect can expand local capillaries, promote cell expansion into a porous state, promote drug absorption, and accelerate microcirculation. Metabolism plays a therapeutic role in promoting blood circulation and removing blood stasis, and truly embodies the treatment principle of "general rule does not hurt" in the theory of traditional Chinese medicine. And tourmaline, medical stone etc. are also not reported as one of the active ingredients of the gel ointment for the treatment of acute and chronic sprains and soft tissue injury types.

由于中药中某些成分影响凝胶组合物的交联,该影响一直是本领域一个亟待解决的难题。本专利有效解决了凝胶膏剂中的中药某些成分对交联性能的影响,同时在凝胶组合物中引入了远红外材料托玛琳粉、麦饭石粉等材料,在原有的治疗急、慢性扭伤、软组织损伤的基础上,同时兼有一定的理疗功效。Since certain ingredients in traditional Chinese medicine affect the crosslinking of the gel composition, this effect has always been a difficult problem to be solved in this field. This patent effectively solves the influence of certain components of traditional Chinese medicine in the gel ointment on the crosslinking performance. At the same time, far-infrared materials tourmaline powder, medical stone powder and other materials are introduced into the gel composition. On the basis of chronic sprains and soft tissue injuries, it also has certain physical therapy effects.

发明内容 Contents of the invention

本发明旨在提供一种特定配方的含有远红外材料的凝胶组合物,使得以其为膏体的凝胶膏剂(巴布剂)具有了理(磁)疗功效;同时该凝胶组合物又具有很好的交联性能,使得以其为膏体的凝胶膏剂在贴敷时不会出现膏体渗布现象。The present invention aims to provide a gel composition containing far-infrared materials of a specific formula, so that the gel ointment (cataplasm) with it as paste has physical (magnetic) therapeutic effects; It also has good cross-linking performance, so that the gel ointment using it as a paste will not appear the phenomenon of paste seepage when it is applied.

本发明的第二目的是提供上述凝胶组合物的制备方法。The second object of the present invention is to provide a preparation method of the above-mentioned gel composition.

本发明的第三目的是提供一种含有上述凝胶组合物的凝胶膏剂。The third object of the present invention is to provide a gel ointment containing the above gel composition.

在本发明的第一方面,提供了一种远红外凝胶组合物,以所述凝胶组合物的总重量计,它含有以下组分:In a first aspect of the present invention, a kind of far-infrared gel composition is provided, in terms of the total weight of the gel composition, it contains the following components:

远红外材料3~7wt%、植物提取物20~35wt%、丙烯酸树脂1~4wt%、交联剂0.1~0.4wt%、保湿剂20~35wt%、透皮促进剂1.5~3.0wt%、填充剂1~3wt%、粘合剂5~7wt%、余量为水;Far-infrared material 3-7wt%, plant extract 20-35wt%, acrylic resin 1-4wt%, cross-linking agent 0.1-0.4wt%, moisturizer 20-35wt%, skin penetration accelerator 1.5-3.0wt%, filling 1-3wt% of the agent, 5-7wt% of the binder, and the balance is water;

其中所述远红外材料选自托玛琳或麦饭石;所述丙烯酸树脂选自丙烯酸与丙烯酸钠的共聚物或聚丙烯酸钠。Wherein the far-infrared material is selected from tourmaline or medical stone; the acrylic resin is selected from the copolymer of acrylic acid and sodium acrylate or sodium polyacrylate.

在另一优选例中,所述植物提取物由芙蓉、辣椒和赤小豆三种中药的提取物混合而成。In another preferred example, the plant extract is prepared by mixing the extracts of three traditional Chinese medicines: hibiscus, capsicum and red bean.

在另一优选例中,所述交联剂选自甘羟铝、甘氨基酸、或过氧化二异丙苯中的一种或几种。In another preferred example, the crosslinking agent is selected from one or more of aluminum glyoxate, glycamino acid, or dicumyl peroxide.

在另一优选例中,所述保湿剂选自甘油、丙二醇、山梨醇、或聚乙二醇中的一种或几种。In another preferred example, the humectant is selected from one or more of glycerin, propylene glycol, sorbitol, or polyethylene glycol.

在另一优选例中,所述透皮促进剂选自氮酮、丙二醇、或桉叶油中的一种或几种。In another preferred example, the skin penetration enhancer is selected from one or more of azone, propylene glycol, or eucalyptus oil.

在另一优选例中,所述填充剂选自高岭土、硅藻土、或滑石粉中的一种或几种。In another preferred example, the filler is selected from one or more of kaolin, diatomaceous earth, or talc.

在另一优选例中,所述粘合剂选自羧甲基纤维素、羧甲基纤维素钠、聚乙烯醇、或聚乙烯吡咯烷酮中的一种或几种。In another preferred example, the binder is selected from one or more of carboxymethylcellulose, sodium carboxymethylcellulose, polyvinyl alcohol, or polyvinylpyrrolidone.

在本发明的第二方面,提供了一种上述的本发明的远红外凝胶组合物的制备方法。In the second aspect of the present invention, a method for preparing the above-mentioned far-infrared gel composition of the present invention is provided.

在本发明的第三方面,提供了一种凝胶膏剂,所述凝胶膏剂含有上述的本发明的远红外凝胶组合物。In the third aspect of the present invention, a gel paste is provided, which contains the above-mentioned far-infrared gel composition of the present invention.

本发明各个方面的细节将在随后的章节中得以详尽描述。通过下文以及权利要求的描述,本发明的特点、目的和优势将更为明显。Details of various aspects of the invention are set forth in the ensuing sections. The features, objects and advantages of the present invention will be more apparent from the following description and claims.

具体实施方式 Detailed ways

发明人经过广泛而深入的研究,意外地发现了一种含有远红外材料、植物提取物、保湿剂、交联剂、丙烯酸树脂、填充剂、粘合剂等成分的凝胶组合物。当这些成分的含量在一个适当的范围内时,所得到的凝胶组合物可以释放出远红外线,使得以其为膏体的凝胶膏剂具有了理(磁)疗功效;同时该凝胶组合物又具有很好的交联性能,使得以其为膏体的凝胶膏剂在贴敷时不会出现膏体渗漏现象,使用方便。After extensive and in-depth research, the inventor unexpectedly discovered a gel composition containing far-infrared materials, plant extracts, moisturizing agents, cross-linking agents, acrylic resins, fillers, adhesives and other components. When the content of these components is in an appropriate range, the resulting gel composition can release far infrared rays, so that the gel ointment with it as paste has physical (magnetic) therapeutic effects; The compound has good cross-linking properties, so that the gel ointment using it as a paste will not leak the paste when it is applied, and it is convenient to use.

远红外材料Far infrared material

本发明使用的远红外材料包括托玛琳、麦饭石、生物炭等。它们通过吸收人体热量,释放出远红外线、负离子、亚离子、矿物元素等物质。释放出的远红外线作用于人体,产生共振吸收及穿透皮层组织,直接作用于血管和神经,触发人体产生引起组织兴奋的能量,产生非热效应,导致毛细血管扩张,微循环血流量增加,促进全身血液循环和新陈代谢,从而起到治疗慢性病的效果。此外,远红外材料本身的自热效应对于热型的凝胶膏剂亦具有提高热感的效果。本发明优选使用的远红外材料为托玛琳、麦饭石等。其用量范围为3~7wt%,优选范围为3.2~6.8wt%The far-infrared materials used in the present invention include tourmaline, medical stone, biochar and the like. They absorb the heat of the human body and release far-infrared rays, negative ions, sub-ions, mineral elements and other substances. The released far-infrared rays act on the human body, produce resonance absorption and penetrate cortical tissue, directly act on blood vessels and nerves, trigger the human body to generate energy that causes tissue excitement, and produce non-thermal effects, resulting in telangiectasia, increased microcirculatory blood flow, and promote Whole body blood circulation and metabolism, so as to play the effect of treating chronic diseases. In addition, the self-heating effect of the far-infrared material itself also has the effect of improving the thermal sensation of the thermal gel paste. The preferred far-infrared materials used in the present invention are tourmaline, medical stone and the like. Its dosage range is 3~7wt%, and the preferred range is 3.2~6.8wt%

植物(中药)提取物Plant (Chinese Medicine) Extract

本发明使用的植物提取物可用本领域的常规方法如水提取、有机溶剂提取、超临界萃取等从多种中药材植物中直接提取获得;亦可将多种植物提取物混合使用。优选使用包括芙蓉、辣椒、赤小豆三种植物提取物的混合提取物(如实施例中所用),以上数药合用对消肿、行血、止痛等有良效。其用量范围为20~35wt%,优选范围为22~33wt%。The plant extracts used in the present invention can be directly extracted from various Chinese medicinal plants by conventional methods in the field such as water extraction, organic solvent extraction, supercritical extraction, etc.; various plant extracts can also be mixed for use. It is preferable to use a mixed extract including three plant extracts of hibiscus, capsicum, and red bean (as used in the examples). The combination of the above drugs has good effects on detumescence, blood circulation, and pain relief. Its usage range is 20-35wt%, and the preferred range is 22-33wt%.

丙烯酸树脂Acrylic

本发明使用的丙烯酸树脂药用辅料,包括一类由丙烯酸(或甲基丙烯酸及它们的酯如:甲酯、乙酯等)以本体(一种单体)聚合,或者与甲基丙烯酸(或它的酯如:甲酯、乙酯、二甲胺基乙酯等)以二种单体(二元)按一定比例共聚而形成的高分子化合物。本发明优选使用“部分被中和的聚丙烯酸”(即“丙烯酸与丙烯酸钠的共聚物”,如Viscomate NP600、NP700、NP800),用量范围为1~4wt%,优选范围为1.2~3.8wt%。Acrylic resin pharmaceutical excipients used in the present invention include a class of acrylic acid (or methacrylic acid and their esters such as: methyl ester, ethyl ester, etc.) polymerized in bulk (a monomer), or with methacrylic acid (or Its esters (such as: methyl ester, ethyl ester, dimethylamino ethyl ester, etc.) are polymer compounds formed by copolymerization of two monomers (binary) in a certain proportion. The present invention preferably uses "partially neutralized polyacrylic acid" (that is, "copolymer of acrylic acid and sodium acrylate", such as Viscomate NP600, NP700, NP800), and the dosage range is 1 to 4 wt%, and the preferred range is 1.2 to 3.8 wt%. .

交联剂crosslinking agent

本领域常用的凝胶膏剂交联剂多为高价金属盐,主要为铝盐,如结晶氯化铝、硫酸铝、甘氨酸铝、明矾或者复合铝盐等。本发明优选使用的交联剂为甘羟铝、甘氨基酸、过氧化二异丙苯等。用量范围为0.1~0.4wt%,优选范围为0.12~0.38wt%。Most of the crosslinking agents for gel pastes commonly used in this field are high-valent metal salts, mainly aluminum salts, such as crystalline aluminum chloride, aluminum sulfate, aluminum glycinate, alum or composite aluminum salts. The cross-linking agent preferably used in the present invention is aluminum glycolate, glycine amino acid, dicumyl peroxide and the like. The dosage range is 0.1-0.4wt%, and the preferred range is 0.12-0.38wt%.

保湿剂moisturizer

凝胶膏剂的含水量大,解决保湿、保水问题是凝胶膏剂制备中的重要环节。保湿剂能与凝胶膏剂中的水溶合、络合、缔合,防止水的蒸发和损失,保持含水量,使膏剂基质的平衡与稳定免遭破坏。因此,选择适宜的保湿剂十分重要。本发明优选使用的保湿剂包括甘油、丙二醇、山梨醇、聚乙二醇等。用量范围为20~35wt%,优选范围为20~33wt%。The water content of the gel paste is large, and solving the problem of moisturizing and water retention is an important link in the preparation of the gel paste. The humectant can dissolve, complex and associate with the water in the gel ointment, prevent the evaporation and loss of water, maintain the water content, and prevent the balance and stability of the ointment matrix from being damaged. Therefore, it is very important to choose a suitable moisturizer. Preferred humectants for use in the present invention include glycerin, propylene glycol, sorbitol, polyethylene glycol, and the like. The dosage range is 20-35wt%, and the preferred range is 20-33wt%.

透皮促进剂Skin penetration enhancer

透皮吸收促进剂是指所有能够增加药物透皮吸收速度或增加药物透皮量的物质。本领域常用的透皮吸收促进剂包括二甲基亚砜、氮酮(Azone)、薄荷油、冰片、桉叶油、丙二醇等。本发明优选使用的透皮促进剂为氮酮、桉叶油等。其用量范围为1.5~3.0wt%,优选范围为1.7~2.8wt%。Transdermal absorption enhancers refer to all substances that can increase the rate of drug transdermal absorption or increase the amount of drug transdermal. Transdermal absorption enhancers commonly used in this field include dimethyl sulfoxide, azone, peppermint oil, borneol, eucalyptus oil, propylene glycol, and the like. The skin penetration enhancer preferably used in the present invention is azone, eucalyptus oil and the like. Its usage range is 1.5-3.0 wt%, preferably 1.7-2.8 wt%.

填充剂filler

填充剂在外用贴膏凝胶膏剂中使用具有为凝胶膏剂赋性及成型作用,且能改善黏性及可塑性,使凝胶膏剂达到贴于皮肤应有的黏附力,又具有必须的内聚力达到应有的技术要求。本发明使用的填充剂系列选自高岭土、硅藻土、滑石粉、石墨、炭黑、氧化铝粉、玻璃粉、石棉粉、云母粉、石英粉、碳纤维、粉末状软木、金刚砂等。本发明优选使用的填充剂包括高岭土、硅藻土、滑石粉。其用量范围为1~3wt%,优选范围为1.2~2.8wt%。The use of fillers in external plaster gel paste has the function of imparting and shaping the gel paste, and can improve the viscosity and plasticity, so that the gel paste can achieve the adhesion force that should be attached to the skin, and have the necessary cohesion to achieve the desired effect. There are technical requirements. The filler series used in the present invention are selected from kaolin, diatomaceous earth, talcum powder, graphite, carbon black, alumina powder, glass powder, asbestos powder, mica powder, quartz powder, carbon fiber, powdered cork, corundum and the like. Preferred fillers for use in the present invention include kaolin, diatomaceous earth, and talc. Its usage range is 1-3wt%, and the preferred range is 1.2-2.8wt%.

粘合剂Adhesive

粘合剂是凝胶膏剂膏体产生黏性的主要物质,多为高分子化合物组成,按其来源可以分为天然水溶性高分子物质和半合成及合成亲水性高分子物质。本领域常用的天然水溶性高分子物质有明胶、西黄芪胶、阿拉伯胶、琼脂、白及胶、桃胶、淀粉、海藻酸盐等。其中明胶起泡性很强,成膜性良好,在非交联型凝胶膏剂中,常作为凝胶骨架成分,但与琼脂相比,其凝固力较弱。西黄芪胶、桃胶的作用主要是提高成型前基质的稠度,同时可以改善凝胶膏剂对皮肤的黏着力。半合成及合成亲水性高分子黏着剂常用的有甲基纤维素、羧甲基纤维素及其钠盐(CMC-Na)、聚丙烯酸钠、聚乙烯醇(PVA)、聚乙烯吡咯烷酮(PVP)、卡波姆、黄原胶等。本发明优选使用的粘合剂包括CMC-Na、PVP K-90等。其用量范围为5~7wt%,优选范围为5.2~6.8wt%。Adhesive is the main substance that produces the viscosity of gel paste, mostly composed of polymer compounds, which can be divided into natural water-soluble polymer substances and semi-synthetic and synthetic hydrophilic polymer substances according to their sources. Natural water-soluble polymer substances commonly used in this field include gelatin, tragacanth gum, acacia gum, agar, white gelatin, peach gum, starch, alginate and the like. Among them, gelatin has strong foaming property and good film-forming property. In non-crosslinked gel paste, it is often used as a gel skeleton component, but compared with agar, its coagulation force is weaker. The role of tragacanth gum and peach gum is mainly to increase the consistency of the matrix before molding, and at the same time to improve the adhesion of the gel ointment to the skin. Semi-synthetic and synthetic hydrophilic polymer adhesives commonly used are methyl cellulose, carboxymethyl cellulose and its sodium salt (CMC-Na), sodium polyacrylate, polyvinyl alcohol (PVA), polyvinylpyrrolidone (PVP ), carbomer, xanthan gum, etc. The preferred binding agent used in the present invention includes CMC-Na, PVP K-90 etc. Its usage range is 5-7wt%, and the preferred range is 5.2-6.8wt%.

除上述成分外,本发明的凝胶组合物还可以含有一种或多种其他添加剂,如防腐剂、pH调节剂等。常用的防腐剂包括但不限于:安息香酸(苯甲酸)、LiquidGermall pus、己二稀酸、去水醋酸、对羟苯甲酸、对羟苯甲酸乙酯、对羟苯甲酸丙酯、对羟苯甲酸丁酯、对羟苯甲酸异丙酯、对羟苯甲酸异丁酯、硼砂、水杨酸甲酯等。本发明优选使用的防腐剂为水杨酸甲酯、Liquid Germall pus。其用量范围为0.1~1.5wt%,优选范围为0.2~1.0wt%。pH调节剂可调节凝胶组合物的pH值,包括酒石酸或者柠檬酸等。本发明优选使用酒石酸。其用量范围为0.1~0.5wt%,优选范围为0.12~0.48wt%。In addition to the above ingredients, the gel composition of the present invention may also contain one or more other additives, such as preservatives, pH regulators and the like. Commonly used preservatives include, but are not limited to: benzoic acid (benzoic acid), LiquidGermall pus, adipic acid, anhydrous acetic acid, paraben, ethylparaben, propylparaben, paraben Butyl formate, isopropyl paraben, isobutyl paraben, borax, methyl salicylate, etc. Preservatives preferably used in the present invention are methyl salicylate, Liquid Germall pus. Its amount ranges from 0.1 to 1.5 wt%, preferably from 0.2 to 1.0 wt%. The pH regulator can adjust the pH value of the gel composition, including tartaric acid or citric acid and the like. Tartaric acid is preferably used in the present invention. Its amount ranges from 0.1 to 0.5 wt%, preferably from 0.12 to 0.48 wt%.

本发明的凝胶组合物可用本领域的常规方法制备获得,先取配方量的保湿剂、交联剂、粘合剂、填充剂、透皮吸收促进剂、远红外材料等制备油相,再取配方量的植物提取物和水制备水相,然后将水相加入油相中搅拌均匀即得。所制得的本发明的凝胶组合物是一种有一定内聚力的粘稠状胶体,将其均匀涂于背衬无纺布上,覆盖防黏膜后放置,让其进一步完成交联,最后经过裁剪、包装后即得临床上使用的定型凝胶膏剂。The gel composition of the present invention can be prepared by conventional methods in the art. First, take the moisturizing agent, crosslinking agent, adhesive, filler, transdermal absorption accelerator, far-infrared material, etc. of the formula to prepare the oil phase, and then take Prepare the water phase with the plant extract and water in the prescribed amount, then add the water phase into the oil phase and stir evenly. The prepared gel composition of the present invention is a viscous colloid with a certain cohesive force, which is evenly coated on the backing non-woven fabric, covered with an anti-adhesive film, placed, and allowed to further complete cross-linking, and finally passed After cutting and packaging, the clinically used sizing gel ointment can be obtained.

本发明的凝胶组合物所含远红外材料的远红外发射率≥88%(国家权威机构检测),负离子释放量1060个/cm3。由于加入了远红外材料,使本发明的凝胶组合物具有了磁疗的功能。托玛琳、麦饭石等远红外材料释放的远红外线、负离子、亚离子以及矿物质元素等被人体吸收后,能够促进人体的血液循环和新陈代谢,从而产生美容、美体和治疗慢性病的效果。同时,本发明的凝胶组合物由于其独特配方而具有良好的交联性能,在贴敷时不会出现膏体渗漏现象,使用方便。The far-infrared material contained in the gel composition of the present invention has a far-infrared emissivity of ≥ 88% (detected by a national authority), and an anion release of 1060/cm 3 . Due to the addition of far-infrared materials, the gel composition of the present invention has the function of magnetic therapy. The far-infrared rays, negative ions, sub-ions and mineral elements released by far-infrared materials such as tourmaline and medical stone are absorbed by the human body, which can promote the blood circulation and metabolism of the human body, thereby producing beauty, body and treatment of chronic diseases. At the same time, the gel composition of the present invention has good cross-linking performance due to its unique formula, no ointment leakage phenomenon occurs when sticking, and is convenient to use.

下面结合具体实施例,进一步阐述本发明。应理解,这些实施例仅用于说明本发明而不用于限制本发明的范围。下列实施例中未注明具体条件的实验方法,通常按照常规条件或按照制造厂商所建议的条件。除非另外说明,否则所有的百分数、比率、比例、或份数按重量计。Below in conjunction with specific embodiment, further illustrate the present invention. It should be understood that these examples are only used to illustrate the present invention and are not intended to limit the scope of the present invention. For the experimental methods without specific conditions indicated in the following examples, usually follow the conventional conditions or the conditions suggested by the manufacturer. All percentages, ratios, ratios, or parts are by weight unless otherwise indicated.

本发明中的重量百分比中的单位是本领域技术人员所熟知的,例如是指100个重量单位的制剂中所含有效成分的重量,符号为“wt%”。The units in the weight percent in the present invention are well known to those skilled in the art, for example, it refers to the weight of active ingredients contained in 100 weight units of the preparation, and the symbol is "wt%".

除非另行定义,文中所使用的所有专业与科学用语与本领域熟练人员所熟悉的意义相同。此外,任何与所记载内容相似或均等的方法及材料皆可应用于本发明方法中。文中所述的较佳实施方法与材料仅作示范之用。Unless otherwise defined, all professional and scientific terms used herein have the same meanings as commonly understood by those skilled in the art. In addition, any methods and materials similar or equivalent to those described can be applied to the method of the present invention. The preferred implementation methods and materials described herein are for demonstration purposes only.

本发明提到的上述特征,或实施例提到的特征可以任意组合。本专利说明书所揭示的所有特征可与任何组合物形式并用,说明书中所揭示的各个特征,可以任何可提供相同、均等或相似目的的替代性特征取代。因此除有特别说明,所揭示的特征仅为均等或相似特征的一般性例子。The above-mentioned features mentioned in the present invention, or the features mentioned in the embodiments can be combined arbitrarily. All the features disclosed in this patent specification can be used in combination with any combination, and each feature disclosed in the specification can be replaced by any alternative feature that can provide the same, equivalent or similar purpose. Therefore, unless otherwise specified, the disclosed features are only general examples of equivalent or similar features.

实施例1凝胶组合物由下列成份按重量比混合构成:Embodiment 1 The gel composition is formed by mixing the following ingredients by weight:

Figure BDA0000133527500000061
Figure BDA0000133527500000061

制备方法如下:The preparation method is as follows:

1、制备油相:准确称取配方量的甘油,甘羟铝,CMC-Na、PVP K-90、NP600、高岭土、水杨酸甲酯、氮酮、桉叶油、丙二醇、托玛琳粉等,以上物质放于敞开容器中搅拌分散均匀后,放置待用;1. Preparation of oil phase: Accurately weigh the amount of glycerin, aluminum glycerol, CMC-Na, PVP K-90, NP600, kaolin, methyl salicylate, azone, eucalyptus oil, propylene glycol, tourmaline powder etc., put the above substances in an open container, stir and disperse evenly, and then place it for use;

2、制备水相:准确称取配方量的酒石酸,再加入纯化水,不断搅拌使其溶解,然后加入植物提取物,继续搅拌直至水相成均匀的溶液;2. Prepare the water phase: Accurately weigh the tartaric acid in the formula, add purified water, stir continuously to dissolve it, then add plant extracts, and continue stirring until the water phase becomes a uniform solution;

3、制备凝胶膏剂基质:将水相迅速加到油相中,立即搅拌,先快速搅拌2分钟后中慢速搅拌6分钟,此时形成有一定内聚力的粘稠状胶体,将胶体均匀涂于背衬无纺布上,覆盖防黏膜后放置,让其进一步完成交联。经裁剪包装制得凝胶膏剂。3. Prepare the gel paste base: quickly add the water phase to the oil phase, stir immediately, first stir quickly for 2 minutes, then stir at medium and slow speed for 6 minutes, at this time a viscous colloid with a certain cohesion is formed, spread the colloid evenly Put it on the backing non-woven fabric, cover it with anti-adhesive film, let it further complete the cross-linking. The gel ointment is obtained through cutting and packaging.

对制得的凝胶膏剂膏体进行赋形性测试,结果显示:膏面无流淌现象,符合要求。The excipient test was carried out on the prepared gel ointment paste, and the results showed that there was no flow phenomenon on the paste surface, which met the requirements.

实施例2凝胶组合物由下列成份按重量比混合构成Embodiment 2 The gel composition is composed of the following ingredients mixed by weight

Figure BDA0000133527500000071
Figure BDA0000133527500000071

按照实施例1的制备方法制备凝胶膏剂。对本实施例配方的凝胶膏剂膏体进行赋形性测试,结果显示:膏面无流淌现象,符合要求。The gel ointment was prepared according to the preparation method of Example 1. The excipient test was carried out on the gel ointment paste of the formula in this example, and the results showed that the paste surface did not flow, which met the requirements.

实施例3凝胶组合物由下列成份按重量比混合构成Embodiment 3 The gel composition is composed of the following ingredients mixed by weight

按照实施例1的制备方法制备凝胶膏剂。对本实施例配方的凝胶膏剂膏体进行赋形性测试,结果显示:膏面无流淌现象,符合要求。The gel ointment was prepared according to the preparation method of Example 1. The excipient test was carried out on the gel ointment paste of the formula in this example, and the results showed that the paste surface did not flow, which met the requirements.

实施例4凝胶组合物由下列成份按重量比混合构成Embodiment 4 The gel composition is formed by mixing the following ingredients by weight

Figure BDA0000133527500000073
Figure BDA0000133527500000073

按照实施例1的制备方法制备凝胶膏剂。对本实施例配方的凝胶膏剂膏体进行赋形性测试,结果显示:膏面无流淌现象,符合要求。The gel ointment was prepared according to the preparation method of Example 1. The excipient test was carried out on the gel ointment paste of the formula in this example, and the results showed that the paste surface did not flow, which met the requirements.

实施例5凝胶组合物由下列成份按重量比混合构成Example 5 The gel composition is composed of the following ingredients mixed by weight

Figure BDA0000133527500000082
Figure BDA0000133527500000082

按照实施例1的制备方法制备凝胶膏剂。对本实施例配方的凝胶膏剂膏体进行赋形性测试,结果显示:膏面无流淌现象,符合要求。The gel ointment was prepared according to the preparation method of Example 1. The excipient test was carried out on the gel ointment paste of the formula in this example, and the results showed that the paste surface did not flow, which met the requirements.

实施例6凝胶组合物由下列成份按重量比混合构成Embodiment 6 The gel composition is formed by mixing the following ingredients in a weight ratio

Figure BDA0000133527500000083
Figure BDA0000133527500000083

按照实施例1的制备方法制备凝胶膏剂。对本实施例配方的凝胶膏剂膏体进行赋形性测试,结果显示:膏面无流淌现象,符合要求。The gel ointment was prepared according to the preparation method of Example 1. The excipient test was carried out on the gel ointment paste of the formula in this example, and the results showed that the paste surface did not flow, which met the requirements.

本发明所涉及的多个方面已做如上阐述。然而,应理解的是,在不偏离本发明精神之前提下,本领域专业人员可对其进行等同改变和修饰,所述改变和修饰同样落入本专利申请之权利要求的覆盖范围。Various aspects involved in the present invention have been described above. However, it should be understood that, without departing from the spirit of the present invention, equivalent changes and modifications can be made by those skilled in the art, and the changes and modifications also fall within the coverage of the claims of this patent application.

Claims (8)

1.一种远红外凝胶组合物,其特征在于,以所述凝胶组合物的总重量计,它含有以下组分:1. a far-infrared gel composition, characterized in that, in terms of the total weight of the gel composition, it contains the following components: 远红外材料3~7wt%、植物提取物20~35wt%、丙烯酸树脂1~4wt%、交联剂0.1~0.4wt%、保湿剂20~35wt%、透皮促进剂1.5~3.0wt%、填充剂1~3wt%、粘合剂5~7wt%、余量为水;Far-infrared material 3-7wt%, plant extract 20-35wt%, acrylic resin 1-4wt%, cross-linking agent 0.1-0.4wt%, moisturizer 20-35wt%, skin penetration accelerator 1.5-3.0wt%, filling 1-3wt% of the agent, 5-7wt% of the binder, and the balance is water; 其中所述远红外材料选自托玛琳或麦饭石;所述丙烯酸树脂选自丙烯酸与丙烯酸钠的共聚物或聚丙烯酸钠。Wherein the far-infrared material is selected from tourmaline or medical stone; the acrylic resin is selected from the copolymer of acrylic acid and sodium acrylate or sodium polyacrylate. 2.权利要求1的远红外凝胶组合物,其特征在于,所述植物提取物由芙蓉、辣椒和赤小豆三种中药的提取物混合而成。2. The far-infrared gel composition according to claim 1, characterized in that, said plant extract is formed by mixing the extracts of three kinds of Chinese medicines of hibiscus, capsicum and red bean. 3.权利要求1的远红外凝胶组合物,其特征在于,所述交联剂选自甘羟铝、甘氨基酸、或过氧化二异丙苯中的一种或几种。3. The far-infrared gel composition according to claim 1, characterized in that, the crosslinking agent is selected from one or more of aluminum glycolate, glycine amino acid, or dicumyl peroxide. 4.权利要求1的远红外凝胶组合物,其特征在于,所述保湿剂选自甘油、丙二醇、山梨醇、或聚乙二醇中的一种或几种。4. The far-infrared gel composition according to claim 1, characterized in that, said humectant is selected from one or more of glycerin, propylene glycol, sorbitol, or polyethylene glycol. 5.权利要求1的远红外凝胶组合物,其特征在于,所述透皮促进剂选自氮酮、丙二醇、或桉叶油中的一种或几种。5. The far-infrared gel composition according to claim 1, characterized in that, said transdermal accelerator is selected from one or more of azone, propylene glycol, or eucalyptus oil. 6.权利要求1的远红外凝胶组合物,其特征在于,所述填充剂选自高岭土、硅藻土、或滑石粉中的一种或几种。6. The far-infrared gel composition according to claim 1, characterized in that, the filler is selected from one or more of kaolin, diatomaceous earth, or talcum powder. 7.权利要求1的远红外凝胶组合物、其特征在于,所述粘合剂选自羧甲基纤维素、羧甲基纤维素钠、聚乙烯醇、或聚乙烯吡咯烷酮中的一种或几种。7. the far-infrared gel composition of claim 1, is characterized in that, described binding agent is selected from one or the other in carboxymethylcellulose, sodium carboxymethylcellulose, polyvinyl alcohol or polyvinylpyrrolidone Several kinds. 8.一种凝胶膏剂,其特征在于,所述凝胶膏剂含有权利要求1~7的任一远红外凝胶组合物。8. A gel paste, characterized in that the gel paste contains any far-infrared gel composition according to claims 1-7.
CN201210022600.9A 2012-02-01 2012-02-01 Preparation of a kind of far-infrared gel composition and gel ointment Active CN103239426B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210022600.9A CN103239426B (en) 2012-02-01 2012-02-01 Preparation of a kind of far-infrared gel composition and gel ointment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210022600.9A CN103239426B (en) 2012-02-01 2012-02-01 Preparation of a kind of far-infrared gel composition and gel ointment

Publications (2)

Publication Number Publication Date
CN103239426A true CN103239426A (en) 2013-08-14
CN103239426B CN103239426B (en) 2014-11-12

Family

ID=48919531

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210022600.9A Active CN103239426B (en) 2012-02-01 2012-02-01 Preparation of a kind of far-infrared gel composition and gel ointment

Country Status (1)

Country Link
CN (1) CN103239426B (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103451973A (en) * 2013-09-03 2013-12-18 上海波顺服饰有限公司 Far infrared fabric and preparation method thereof as well as healthcare shoulder pad made of far infrared fabric
CN103932408A (en) * 2014-04-18 2014-07-23 乔志宏 Externally used medicine waistcoat for treating gasp syndrome and medicine preparation method
CN104958244A (en) * 2015-06-22 2015-10-07 上海梅派化妆品有限公司 Multipurpose product capable of improving in-vivo and in-vitro metabolism of body skin, whitening skin and resisting ageing
CN105362253A (en) * 2014-08-29 2016-03-02 安徽华艾生物科技有限公司 Novel far-infrared gel paste
CN114470145A (en) * 2022-01-25 2022-05-13 河北化工医药职业技术学院 Warm moxibustion type gel plaster for relieving pain of bone diseases and preparation method thereof
CN115160869A (en) * 2022-07-04 2022-10-11 北京慧盈科技有限公司 Energized biological coating liquid material, preparation method thereof and energized biological coating

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1714838A (en) * 2005-06-17 2006-01-04 吴湘君 Medical gel and its preparing method and device
CN101301339A (en) * 2008-06-20 2008-11-12 牛天卓 Babu far infrared medicinal plaster for treating arthralgia and myalgia, and wind-cold syndrome and numbness
CN101780169A (en) * 2010-03-10 2010-07-21 广州白云山制药股份有限公司白云山何济公制药厂 Traumatic injury analgesic cataplasm preparation and preparation method thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1714838A (en) * 2005-06-17 2006-01-04 吴湘君 Medical gel and its preparing method and device
CN101301339A (en) * 2008-06-20 2008-11-12 牛天卓 Babu far infrared medicinal plaster for treating arthralgia and myalgia, and wind-cold syndrome and numbness
CN101780169A (en) * 2010-03-10 2010-07-21 广州白云山制药股份有限公司白云山何济公制药厂 Traumatic injury analgesic cataplasm preparation and preparation method thereof

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103451973A (en) * 2013-09-03 2013-12-18 上海波顺服饰有限公司 Far infrared fabric and preparation method thereof as well as healthcare shoulder pad made of far infrared fabric
CN103451973B (en) * 2013-09-03 2015-08-05 上海波顺服饰有限公司 The Health shoulder pad of far infrared fabric, its preparation method and preparation thereof
CN103932408A (en) * 2014-04-18 2014-07-23 乔志宏 Externally used medicine waistcoat for treating gasp syndrome and medicine preparation method
CN103932408B (en) * 2014-04-18 2016-08-24 乔志宏 A kind of external used medicine vest treating the syndrome of dyspnea and process for preparing medicine
CN105362253A (en) * 2014-08-29 2016-03-02 安徽华艾生物科技有限公司 Novel far-infrared gel paste
CN104958244A (en) * 2015-06-22 2015-10-07 上海梅派化妆品有限公司 Multipurpose product capable of improving in-vivo and in-vitro metabolism of body skin, whitening skin and resisting ageing
CN114470145A (en) * 2022-01-25 2022-05-13 河北化工医药职业技术学院 Warm moxibustion type gel plaster for relieving pain of bone diseases and preparation method thereof
CN115160869A (en) * 2022-07-04 2022-10-11 北京慧盈科技有限公司 Energized biological coating liquid material, preparation method thereof and energized biological coating

Also Published As

Publication number Publication date
CN103239426B (en) 2014-11-12

Similar Documents

Publication Publication Date Title
CN103239426A (en) Preparation of a kind of far-infrared gel composition and gel ointment
KR101015491B1 (en) Adhesive
US20040156886A1 (en) Sheet-like patch agent
TWI233810B (en) A paster sheet
CN104546802B (en) Treat spontaneous heating herbal application of rheumatic arthritis and preparation method thereof
CN106667970B (en) Flurbiprofen cataplasms
CN105748446A (en) Far infrared magnetic therapy pain relieving plaster
CN105726513A (en) Far-infrared inflammation diminishing and pain alleviating patch
CN105362253A (en) Novel far-infrared gel paste
CN106822049B (en) Novel chemical medicine patch ketoprofen patch and preparation method thereof
CN100391480C (en) Hydrophilic gel pleximetric paste and its preparation
CN106822326B (en) Chinese medicine plaster for treating cervicodynia and its preparation method
CN102850710B (en) Framework material for medical plaster and preparation method thereof
CN101612141B (en) Buprenorphine patch
CN105343149A (en) Application of eucommia ulmoides to preparation of medicinal moxa sticks
CN203829349U (en) Self-heating traditional Chinese medicine patch for treating rheumatic arthritis
US20230381371A1 (en) Polymer hydrogel with slow-release function and preparation method and use thereof
CN101785864A (en) Post-crosslinking hydrophilic patch substrate and preparation method thereof
CN105326818B (en) A kind of diclofenac patch
JPS60260513A (en) Poultice
CN209108136U (en) A kind of external-use gel patch of suppression cancer analgesic
CN112386569A (en) Traditional Chinese medicine gel auxiliary material and application thereof
CN109010773A (en) A kind of graphene pediatric fever stickers and preparation method thereof
CN111658716A (en) Hydrogel magnetic therapy traditional Chinese medicine plaster and preparation method thereof
CN105169176A (en) Children's traditional Chinese medicine sole cooling patch

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20201201

Address after: No. 118, Yedong Road, Chedun Town, Songjiang District, Shanghai, 201611

Patentee after: Fang Shanghai Pharmaceutical Technology Co.,Ltd.

Address before: 200032 7C, Xuhui District Medical College, Shanghai, 69

Patentee before: SHANGHAI CIJI PHARMACEUTICAL Co.,Ltd.

TR01 Transfer of patent right
PE01 Entry into force of the registration of the contract for pledge of patent right

Denomination of invention: Far infrared gel composition and preparation of gel paste

Effective date of registration: 20230517

Granted publication date: 20141112

Pledgee: Shanghai Siling Enterprise Development Partnership (L.P.)

Pledgor: Fang Shanghai Pharmaceutical Technology Co.,Ltd.

Registration number: Y2023310000193

PE01 Entry into force of the registration of the contract for pledge of patent right